Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoid

Pharmacological Research

Volumn 48, Issue 4, 2003, Pages 319-323

  Dong, Feng ^a,b   Ren, Jun ^b  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Glucocorticoid; IGF binding proteins (IGFBPs); Insulin like growth factor I (IGF 1); Nephrotic syndrome (NS)

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; PREDNISOLONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CHILD; DRUG MEGADOSE; FOOD INTAKE; GROWTH DISORDER; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; LONG TERM CARE; MALNUTRITION; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

EID: 0042167446     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00182-8     Document Type: Review

References (38)

1. Dong F., Zhou X., Pang N., Wei M. Effect of glucocorticoid treatment on insulin like growth factor-I and its binding proteins in children with nephrotic syndrome. Chin. Med. J. 115:2002;1383-1385.
2. Zhou X., Loke K.Y., Pillai C.C., How H.K., Yap H.K., Lee K.O. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Eur. J. Endocrinol. 144:2001;237-243.
3. Mauras N. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. Horm. Res. 56(Suppl. 1):2001;13-18.
4. Sedman A., Friedman A., Boineau F., Strife C.F., Fine R. Nutritional management of the child with mild to moderate chronic renal failure. J. Pediatr. 129:1996;s13-s18.
5. Hirschberg R., Adler S. Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications. Am. J. Kidney Dis. 31:1998;901-919.
6. Van Wyk J.J., Smith E.P. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions. J. Clin. Endocrinol. Metab. 84:1999;4349-4354.
7. Foncea R., Andersson M., Ketterman A., Blakesley V., Sapag-Hagar M., Sugden P.H., LeRoith D., Lavandero S. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J. Biol. Chem. 272:1997;19115-19124.
8. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
9. Rubin R., Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73:1995;311-331.
10. Duan C. Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J. Endocrinol. 175:2002;41-54.
11. Wulbrand U., Remmert G., Zofel P., Wied M., Arnold R., Fehmann H.C. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours. Eur. J. Clin. Invest. 30:2000;729-739.
12. Rechler M.M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - what's IGF got to do with it? Endocrinology. 138:1997;2645-2647.
13. Arai T., Busby W. Jr., Clemmons D.R. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology. 137:1996;4571-4575.
14. Cox G.N., McDermott M.J., Merkel E., Stroh C.A., Ko S.C., Squires C.H., Gleason T.M., Russell D. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology. 135:1994;1913-1920.
15. Kratz G., Lake M., Ljungstrom K., Forsberg G., Haegerstrand A., Gidlund M. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp. Cell Res. 202:1992;381-385.
16. Monzavi R., Cohen P. IGFs and IGFBPs: role in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 16:2002;433-447.
17. Ren J., Samson W.K., Sowers J.R. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell Cardiol. 31:1999;2049-2061.
18. Kajantie E., Dunkel L., Rutanen E.M., Seppala M., Koistinen R., Sarnesto A., Andersson S. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J. Clin. Endocrinol. Metab. 87:2002;2171-2179.
19. Norby F.L., Wold L.E., Duan J., Hintz K.K., Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 283:2002;E658-E666.
20. Donath M.Y., Zapf J. Insulin-like growth factor I: an attractive option for chronic heart failure? Drugs Aging. 15:1999;251-254.
21. Khan A.S., Sane D.C., Wannenburg T., Sonntag W.E. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc. Res. 54:2002;25-35.
22. Zumkeller W. IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors. Exp. Rev. Mol. Diagn. 2:2002;473-477.
23. Goya L., Garcia-Segura L.M., Ramos S., Pascual-Leone A.M., Argente J., Martin M.A., Chowen J.A. Interaction between malnutrition and ovarian hormones on the systemic IGF-I axis. Eur. J. Endocrinol. 147:2002;417-424.
24. Smith W.J., Underwood L.E., Clemmons D.R. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J. Clin. Endocrinol. Metab. 80:1995;443-449.
25. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15:1994;80-101.
26. Zadik Z., Frishberg Y., Drukker A., Blachar Y., Lotan D., Levi S., Reifen R. Excessive dietary protein and suboptimal caloric intake have a negative effect on the growth of children with chronic renal disease before and during growth hormone therapy. Metabolism. 47:1998;264-268.
27. Richmond E.J., Uzri A., Rogol A.D. The insulin-like growth factor system in kidney diseases. Nephron. 89:2001;5-9.
28. Haffner D., Tonshoff B., Blum W.F., Vickers M., Siebler T., Cronin M.J., Baxter R.C., Mehls O. Insulin-like growth factors (IGFs) and IGF binding, proteins serum acid-labile subunit and growth hormone binding protein in nephrotic children. Kidney Int. 52:1997;802-810.
29. Lee D.Y., Park S.K., Kim J.S. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome. J. Clin. Endocrinol. Metab. 81:1996;1856-1860.
30. Garin E.H., Grant M.B., Silverstein J.H. Insulinlike growth factors in patients with active nephrotic syndrome. Am. J. Dis. Child. 143:1989;865-867.
31. Thabet M.A., Challa A., Chan W., Liu F., Hintz R.L., Chan J.C. Insulin-like growth factor and growth hormone receptor in nephrotic rats. Am. J. Physiol. 266:1994;E102-E106.
32. Binz K., Schmid C., Bouillon R., Froesch E.R., Jurgensen K., Hunziker E.B. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats. Eur. J. Endocrinol. 130:1994;387-393.
33. Villafuerte B.C., Koop B.L., Pao C.I., Phillips L.S. Glucocorticoid regulation of insulin-like growth factor-binding protein-3. Endocrinology. 136:1995;1928-1933.
34. Allen D.B., Julius J.R., Breen T.J., Attie K.M. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study. J. Clin. Endocrinol. Metab. 83:1998;2824-2829.
35. Jonsson K.B., Frost A., Larsson R., Ljunghall S., Ljunggren O. A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I. Calcif. Tissue Int. 60:1997;30-36.
36. Wuhl E., Haffner D., Offner G., Broyer M., van't Hoff W., Mehls O. Long-term treatment with growth hormone in short children with nephropathic cystinosis. J. Pediatr. 138:2001;880-887.
37. Conover C.A., Hintz R.L., Johnson B.F. Differential effects of glucocorticoids on insulin-like growth factor I action in cultured human fibroblasts. J. Cell Physiol. 163:1995;615-622.
38. Rooman R., Koster G., Bloemen R., Gresnigt R., Buul-Offers S.C. The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice. J. Endocrinol. 163:1999;543-552.